Challenges in clinical trial recruitment are particularly prevalent in PD studies of disease modification, where the population of interest is difficult to find and study design is more complex. In fact, a recent PD clinical study showed that 55.6% of sites fell below projected recruitment goals.

Clinical trials in neurological diseases present a wide range of challenges and special considerations across the board. With the right experienced study team, a patient and disease pathobiology disease centered study process can be applied to mitigate many of those challenges.